It is increased carriage on red cell c'R IND.1' and not solubilization that is the main function of complement in the handling of immunocomplexes (1989)
- Authors:
- Autor USP: BARBOSA, JOSE ELPIDIO - FMRP
- Unidade: FMRP
- Assunto: INFLAMAÇÃO
- Language: Inglês
- Source:
- Título do periódico: Complement and Inflammation
- Volume/Número/Paginação/Ano: v.6 , n.5 , p.310, 1989
- Conference titles: International Complement Workshop
-
ABNT
BARBOSA, José Elpídio et al. It is increased carriage on red cell c'R IND.1' and not solubilization that is the main function of complement in the handling of immunocomplexes. Complement and Inflammation. [S.l.]: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 28 mar. 2024. , 1989 -
APA
Barbosa, J. E., Gatenby, P., Okuda, T., & Lachmann, P. J. (1989). It is increased carriage on red cell c'R IND.1' and not solubilization that is the main function of complement in the handling of immunocomplexes. Complement and Inflammation. Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. -
NLM
Barbosa JE, Gatenby P, Okuda T, Lachmann PJ. It is increased carriage on red cell c'R IND.1' and not solubilization that is the main function of complement in the handling of immunocomplexes. Complement and Inflammation. 1989 ;6 ( 5 ): 310.[citado 2024 mar. 28 ] -
Vancouver
Barbosa JE, Gatenby P, Okuda T, Lachmann PJ. It is increased carriage on red cell c'R IND.1' and not solubilization that is the main function of complement in the handling of immunocomplexes. Complement and Inflammation. 1989 ;6 ( 5 ): 310.[citado 2024 mar. 28 ] - Determinação cinética de atividade anticomplementar
- Estudo da nefrotoxicidade do soro anti-Forssman em cobaias
- Anti-peptide antibody detecting a neo-antigen on the cri stump left on erythrocytes after proteolysis
- Expressão do receptor para complemento tipo 1(CR1) em eritrócitos de pacientes com leishmaniose visceral
- Complement receptor type 1 (CRI) expression on erythrocytes of patients with kala-azar
- Phage display as a novel promising antivenom therapy: a review
- Anticorpo antipeptidio capaz de detectar fragmentos do receptor crl ligado a eritrocitos humanos, apos proteolise
- Production of human monoclonal antibothropic scFv isolated from a nonimmunized phage library
- Anti-peptide antibody that recognises a neo-antigen in the cr1 stimp rmaining on erythrocytes after proteolysis
- Antiveneno do futuro. [Depoimento]
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas